Making HIV medications free or low cost is very important for removing barriers to HIV care access, but it’s not enough to ensure adherence, Kevin Volpp said at IDWeek. HIV/AIDS programs must take behavioral economics into account when designing programs to promote adherence and ensure people living with HIV remain in the cascade of care. […]
HIV
Progress seen in recent years against the HIV pandemic, including in rising numbers of people diagnosed and treated accompanied by dropping rates of incidence and death, […]
Tuberculosis
SYDNEY – When Merinda Sebayang was undergoing treatment for multidrug-resistant TB in Indonesia – a nation with the third highest tuberculosis burden in the world after […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]